This chapter is important and hence we felt that some general information has to be given globally on the physiological research, as we could not do a detailed study being interns in the medical department of the medical services.
6. We had many ethical and medical problems in doing biochemical observations in the gastrointestinal resecates of human GI tract in patients with peptic ulcer who underwent surgical interventions owing to their primary disease;
7.
We participated in the different international forums of GI research (as established persons, future leaders, organizers and responsible persons).
Our main lines of research series of international conferences are as follows:
a. (Copenhagen, Denmark, 1970; Cologne, Germany, 1972; Parádfürdő, Hungary, 1976; Tokyo, Japan, 1980; Boston, USA, 1985; Jerusalem, Israel, 1988; Berlin, Germany, 1991; Kyoto, Japan, 1994; Hong Kong, China, 1997; Budapest-Pécs, Hungary, 2000; Dubrovnik, Croatia, 2003; Osaka, Japan, 2006; Split, Croatia, 2009; Tokyo, Japan, 2012 ) (for details, see Mózsik, 2006b);
b. Another series of international symposiums was established in connection with main World Congresses of the International Union of Pharmacology (from 1984) . The gastrointestinal section of International Union of Pharmacology was established at Montreal (Canada) in 1994 (IUPHAR GI Section); however, this series of the international symposiums started earlier (Pécs, Hungary, 1984; Pécs, Hungary, 1990; Pécs, Hungary, 1995; Sperlonga, Italy, 1996; Pécs, Hungary, 1998; Honolulu, USA, 2002; Kyoto, Japan, 2004; Osaka, Japan, 2006; Honolulu, Hawaii, USA, 2009; Tokyo, Japan, 2012 ) (for details, see Mózsik et al., 2006) ; c. International Symposia on "Cell/Tissue Injury and Cytoprotection/Organoprotection" [Heidelberg, Germany, 1986; Boston, USA, 1989; Long Beach, CA, USA, 2000; 2006; Yalta (Crimea) , Ukraine, 2008; Saint Petersburg, Russia, 2011; Honolulu, USA, 2012; Budapest, Hungary, 2014] ;
d. International Symposia on Gastrointestinal Cytoprotection (Pécs, Hungary, 1983; 1987; 1991; 1995 , 2000 ;
e. International Symposia of the "International Brain-Gut Society" (Lake Arrowhead, Los Angeles, USA, 1988; Pécs, Hungary, 1990; Florence, Italy, 1993; Pécs, Hungary, 1995) ;
f. Interscience World Conferences on Inflammation [Antirheumatics, Analgesics, Immunomodulators (Venice, Italy, 1984; Monte Carlo, France, 1986; 1989; Geneva, Switzerland, 1995; 1998) ].
8. This part of the book has been tried to give a short information on the different membranebound ATP-dependent energy systems with emphasizing the main problems in these fields, however in briefly up to now (we had no these summaries of these studies in our mind during the time of our observations done in GI tract).
We have to emphasize that we have not done a very detailed study on the membrane-bound ATP-dependent energy systems; however, the results of our study (namely the study of the details of ATP splitting by different membrane-bound enzymes, Na + -K + -dependent ATPase and adenylate cyclase, represent different pathways of energy-liberating cellular events) offered us a very successful research possibility in our field. As ATP splitting results in energy liberation of cells, and the circumstances of the ATP resynthesis (by oxidative phosphorylation) confirmed the presence of tissue hypoxia in the GI mucosa under different (e.g., in the ulcerated or the damaged mucosal tissues) experimental and clinical circumstances.
The main lines of the studies on membrane-bound ATP-dependent energy systems were carried dominantly from GI tract, except for H + -K + -ATPase system (we did not participate in these studies), and hence we started with these studies in our field. Furthermore, these studies offered good possibility to understand the presence of tissue hypoxia (anoxia) during the development of mucosal damage, which was suggested as one of the main reasons (or consequences) of peptic ulcer.
Before the demonstrations of our biochemical results, we will give a very short summary of the main membrane-bound ATP-dependent energy systems (of course, not in the gastric mucosa). Active transport is responsible for cells containing relatively high concentrations of potassium ions but low concentrations of sodium ions. The mechanism responsible for this sodiumpotassium pump moves these two ions in opposite directions across the plasma membrane. This was investigated by following the passage of radioactive ions across the plasma membrane of certain cells. It was found that the concentrations of sodium and potassium ions on the two sides of the membrane are independent, which suggests that the same carrier transports both ions. It is now known that the carrier is an ATPase and it pumps three sodium ions of the cell for every two potassium ions pumped in.
The sodium-potassium pump was discovered in the 1950s (Skou, 1957) by Jens Christian Skou (Department of Physiology, Aarhus University, Denmark), who was awarded Nobel Prize in chemistry in 1997 (http://nobelprize.org/chemistry/laureates/1997/index.html). It marked an important step forward in our understanding of how ions get into and out of cells, and it is particularly significant for excitable cells such as nervous cells, which depend on this pump for responding to stimuli and transmitting impulses (Skou, 1965) .
Schematic morphological bases of sodium-potassium pump (Na
The Na + -K + -ATPases belong to the P 2 class and specifically to the P 2c subclass of ATPases. These ATPases are composed of two subunits (α and β). The α-subunit (about 113 kD) binds ATP and both Na + and K + ions and contains the phosphorylation sites typical of the P-type ATPases. The autophosphorylation site is the P domain. The P-type ATPases are also subject to additional phosphorylation events via other kinases. The smaller β-subunit (about 35-kD glycoprotein) is absolutely necessary for activity of the complex. It appears to be critical in facilitating the plasma membrane localization and activation of the α-subunit.
Several isoforms of both α-and β-subunits have been identified that exhibit different kinetic parameters and tissue distribution. There are four α-subunit genes and three β-subunit genes in humans. The α 1 isoform is the predominant form and is ubiquitously expressed. The α 2 isoform is primarily expressed in muscle tissues (skeletal, smooth and cardiac) as well as in adipose tissue, brain and lungs. The α 3 isoform is expressed primarily in the heart and neurons. The α 4 isoform is only expressed in the testes. The β 1 isoform is ubiquitously expressed and is associated with the α-subunit in the ubiquitously expressed α 1 β 1 Na
There are many more detailed parts and interactions of Na 
Main functions of Na

Resting potential
In order to maintain the cell membrane potential, cells keep a low concentration of sodium ions and high levels of potassium within the cell (intracellular). The sodium-potassium pump moves three sodium ions out and moves two potassium ions in, thus in total removing one positive-charge carrier from the intracellular space.
Transport
Export of sodium from the cell provides the driving force for several secondary active transporters, membrane transport proteins, which import glucose, amino acids and other nutrients into the cell by the use of sodium gradient.
Another important task of the Na + -K + -pump is to provide a Na + gradient that is used by certain carrier processes. In the gut, sodium is transported out of the reabsorbing cell on the blood (intestinal fluid) side via the Na + -K + -pump, whereas, on the reabsorbing (luminal) side, the Na + -glucose symporter uses the created Na + gradient as a source of energy to import both Na + and glucose, which is far more efficient than simple diffusion. Similar processes can be found and located in the renal tubular system.
Controlling cell volume
Failure of the Na + -K + pumps can result in swelling of the cell. A cell's osmolarity is the sum of the concentrations of the various ion species and many proteins and other organic compounds inside the cell. When this is higher than the osmolarity outside of the cell, water flows into the cell through osmosis. This can cause the cell to swell up and lyze. The Na (Li et al., 2009; Forrest et al., 2012; Cannon, 2004; Calderon et al., 2011; Young et al., 2008) .
Main steps of mechanism
The following main steps are involved in the mechanism:
• The pump, while binding ATP, binds three intracellular Na • ATP is hydrolyzed, leading to phosphorylation of the pump at a highly conserved aspartate residue and subsequent release of ADP;
• A conformational change in the pump exposes the Na + ions to the outside. The phosphorylated form of the pump has a low affinity for Na + ions, so they are released;
• The pump binds two extracellular K+ ions. This causes the phosphorylation of the pump, reverting it to its previous state, transporting the K+ ions into the cells;
• The unphosphorylated form of the pump has a higher affinity for Na • All three enzymes form covalent E-P intermediates (P-type pumps);
• All three have similar sequences for the large (α) subunit;
• All three are involved in active transport. -ATPase indicate some similarities in the structural building of these enzymes; however, they can be separated from each other by using immunological methods (Stoll and Berglinch, 1987; Sachs, 1987; Chang et al., 1977; Faller et al., 1982; Ganser and Forte, 1973; Lee et al., 1974; 2001; Maclennan et al., 1985; Saccomani et al., 1979 a, b; Sachs, 1977; Sachs et al., 1972; 1980; 1995; Shull et al., 1985; Koenderink et al., 1999; Asano et al., 2003) .
Adenylate cyclase
Short historic background
Sutherland (1951) studied how the hormone epinephrine (adrenaline) signals to regulate the degradation of glycogen to glucose in the liver, thereby increasing glucose output into the blood, so that an organism can respond to stress. He worked alongside future Nobel Prize winners Edmond Fishers and Edwin Krebs, who demonstrated that adenosine triphosphate (ATP) and magnesium were required for phosphorylase activation. Sutherland (1953) agreed to be the chairman of the pharmacology department of Case Western Reserve University in Cleveland and was joined by Theodore R. Rall, "marking the beginning of a long and fruitful period of collaboration between us" [Sutherland EW. Studies on the mechanism of hormone. Science 177: 401-408, 1972 (Lecture delivered 11 December 1971 when he received the Nobel Prize in Physiology or Medicine)]. Sutherland and Rall discovered that epinephrine works by stimulating another chemical messenger, the enzyme glycogen phosphorylase, to begin the sugar-releasing process in the cells (Henion and Sutherland, 1955) . This stimulation occurs by means of an intermediary that Sutherland called it the "second messenger," which he identified as a nucleotide and named cyclic AMP (Sutherland et al., 1957; Sutherland and Rall, 1957; Rall and Sutherland, 1957; 1958; Butcher and Sutherland, 1962; 1965; Klainer et al., 1962; Murad et al., 1962) . As early as 1960, Sutherland suggested that cyclic AMP acts as a "second messenger" for other hormones as well (Sutherland and Rall, 1958 ) (for other summaries, see Butcher, 1966; Sutherland, 1962; Sutherland and Rall, 1960; Sutherland et al., 1962; Sutherland and Robison, 1966; Andrási, 1997) .
Practically at the same time, the discovery of cyclic 3'-5'-AMP appeared in the organ pharmacology (Sutherland et al., 1965; 1968) .
The adenylate cyclase is an enzyme with key regulatory roles in essentially all cells. It is the most polyphyletic known enzyme: six district classes have been described, all catalyzing the same reaction, but representing unrelated gene families with no known sequence or structural homology (Class I AC, Class II AC, Class III AC, Class IV AC, Class V AC and Class VI AC). The effect of adrenaline is via a G protein-signaling cascade, which transmits chemical signals from outside the cell across the membrane to the inside of the cell (cytoplasm). The outside signal (in this case, adrenaline) binds to a receptor, which transmits a signal to the G protein, which transmits a signal to adenylate cyclase, which transmits a signal by converting adenosine triphosphate (ATP) to cyclic adenosine monophosphate (cAMP). Cyclic AMP is known as the so-called "second messenger" (Reece and Campbell, 2002) .
Adenylate cyclases are often activated or inhibited by G proteins, which are coupled to membrane receptors, and thus can respond to hormonal or other stimuli. Following the activation of adenylate cyclase, the resulting cAMP acts as a second messenger by interacting with and regulating other proteins, such as protein kinase A and cyclic nucleotide-gated ions channels.
AC-III structure:
Most class-III adenylate cyclases are transmembrane proteins with 12 transmembrane segments. The protein is organized with six transmembrane segments, the C1 cytoplasmic domain, another six membrane segments and then a second cytoplasmic domain called C1 and C2 regions.
The C1a and C2a sub-domains are homologous and form an intracellular "dimmer" that forms the active site.
There are ten known isoforms of adenylate cyclases in mammals: ADCY1, ADCY2, ADCY3, ADCY4, ADCY5, ADCY6, ADCY7, ADCY8, ADCY9 and ADCY10. These are sometimes called as AC1, AC2, etc., and sometimes Roman numerals are used for these isoforms that all belong to the overall AC class III. They differ mainly in how they are regulated, and are differentially expressed in various tissues throughout mammalian development.
Adenylate cyclase AC-III regulation:
Adenylate cyclase is dually regulated by G proteins (Gs stimulating activity and Gi inhibiting activity) and forskolin, as well as other isoform-specific effectors:
Isoforms III, V and VIII are also stimulated by Ca 
Short personal background
After taking short reviews on these biochemical problems in the nature of living cells, we faced a unique situation, when one of us (GyM) received a fellowship possibility in the Department of Pharmacology, University of Blindern, Oslo, in 1968 -1969 . We encountered these problems in this Department. Furthermore, I worked together with associate professor Ivar Ǿye, who spent 4 years in the Vanderbilt University (Department of Physiology) and worked together with Professor Sutherland on the problems of cyclic AMP.
After returning home (Norway) from USA, Ivar Øye wanted to do his research in the field of cardiac tissues. He wanted to obtain "plasma membrane" materials, and he wanted to use the "membrane materials" for the study of pharmacological regulation of cyclic AMP transformation in the heart muscles. I was moved to this Department at that time, and I had to receive the critically good evaluation of action of these drugs, all of those were able to inhibit the preparations of "membrane materials" from the heart. I had some methodological knowledge gained from our earlier biochemical studies of the stomach. However, my new scientific work offered a new challenge in the gastrointestinal mucosal research.
Furthermore, I had some other affinities to enter into this research field, which are as follows: a. We earlier mentioned that we were not able to understand and explain the results of clinical pharmacology in patients with peptic ulcer. This is because most of the researchers emphasized the key role of vagus nerve (by the increase of gastric acid secretion); thereby the application of various inhibitory drugs was thought to be reasonable in terms of decrease of gastric acid production. However, if we evaluated critically the actions of these drugs, we had to learn that these drugs are able to inhibit the active metabolism in the gastric tissues. Consequently, we can explain the beneficial effects of these drugs on the healing of peptic ulcer (which was explained by impaired tissue metabolism).
We concluded that we have to do some change in paradigm of the peptic ulcer research. These facts and suggestions led us to study the biochemisms in the gastrointestinal mucosa; b. Many neural, hormonal (and pharmacological) factors, discovered absolutely new mechanisms; later, the immunological events could be collected in participation of peptic ulcer disease. Practically, the researchers studied the influences (action) of one or two factors (especially HCl and pepsin secretion, mucus secretion, bicarbonate secretion, prostaglandins, scavengers and antacids, and their different actions) on the stomach (gastrointestinal tract) in respect to development and protection (healing) of peptic ulcer disease. The results of these observations reflect only indirectly to the gastrointestinal tract.
Besides these results, we were uninformed on the biochemical changes in the gastrointestinal tract in time of gastric acid secretion and mucosal damage versus mucosal protection;
c. We wanted to study the biochemism of gastrointestinal tract, and we suggested that the final results (and summary) of different etiological factors can modify the functions of cells in the gastrointestinal tract. The blood supply was a remarkable extracellular factor; however, the changes in the blood flow also produce significant cellular biochemical changes in the target organ; d. A general biochemical approach to study the biochemisms was built up in animal experiments from 1967. Our biochemical methodologies gave absolutely new insight into the biochemism of the gastrointestinal tract.
These biochemical observations were done dominantly on pylorus-ligated rats (as in an acute animal model). One of the most surprising results was to note that similar biochemical changes were detected in both the rumen and glandular parts (Mózsik et al., 1967 a, b) . These results led us to study the changes in both the parts of the rat stomach after chronic "surgical vagotomy," chronic atropine treatment and cholinesterase (neostigmine) inhibitor treatments (for details, refer sections 4.3.1.-4.3.3 of Chapter 4). From the evaluation of the results of clinical pharmacological studies, we conducted biochemical observations in rats after cessation of drug (atropine, cholinesterase inhibitor) treatments.
The evaluation of these biochemical results in rats led us to understand some main lines of cellular biochemistry (cytoplasm, nucleic acids):
a. They were reversible in rat gastric tissues; b. They were irreversible also.
The first one accepted the metabolic changes in biochemistry and the second one accepted the metabolic changes in genetic field (nucleic acids). These reversible and irreversible lines in the biochemical changes especially can be seen during the time of chronic "use" and "disuse" of vagus nerve. In some observations, we studied the changes of tissue levels of ATP, ADP (Mózsik et al., 1970a) and base alterations of nucleic acids in the stomach wall after a chronic atropine treatment (Mózsik et al., 1969b) .
The results of these observations opened our eyes to start new observations with the main cellular functions of cells; -ATPase was used in my works to prove clearly that we really work with "membrane preparates," and these preparates were used to study the functions of adenylate cyclase. It's true that my boos wanted to see and to study these steps in cardiac muscles; however, I used parallelly the gastric mucosa (earlier obtained in rats, later in human gastric resecates) (Mózsik and Øye, 1969) , and we wanted to study the actions of different drugs (epinephrine, ouabain, NaF ) on the adenylate cyclase. The NaF was used as the most powerful compound to stimulate the adenylase cyclase, because it inhibits the activity of all membrane ATPase activity (this fact is well known in the pertinent literature).
Therefore, consequently, I realized two important things during my study tour in Oslo (Norway), namely to prepare the adenylate cyclase from the crude "membrane materials" (from heart muscles and gastric mucosa) and the presence of Na We have to emphasize that the presence of neither Na+-K+-ATPase nor adenylate cyclase was known in animals and especially in humans; f. I suggested that the functions of these enzymes can be modified by different drugs (not by only hormones) under different experimental conditions (including the animal experiments and human medical problems).
